The interaction of oxytocin and vasopressin systems in reducing relapse to methamphetamine abuse
NA Everett - 2022 - figshare.mq.edu.au
Methamphetamine (METH) is a highly addictive psychostimulant. Currently there are no
approved pharmacotherapies for METH dependence, although animal models of drug use …
approved pharmacotherapies for METH dependence, although animal models of drug use …
The role of the vasopressin V1A receptor in oxytocin modulation of methamphetamine primed reinstatement
The neuropeptide oxytocin has shown promise as an effective therapy in pre-clinical models
of methamphetamine (METH) addiction. The nucleus accumbens core (NAcc) has been …
of methamphetamine (METH) addiction. The nucleus accumbens core (NAcc) has been …
[PDF][PDF] 17 Co-Author Contribution
JL Cornish, SJ Baracz - Towards an understanding of the neural … - figshare.mq.edu.au
Addiction to the psychostimulant Methamphetamine (METH) is characterised by high rates of
relapse. Currently there are no approved effective pharmacotherapies for METH …
relapse. Currently there are no approved effective pharmacotherapies for METH …
Oxytocin treatment in the prelimbic cortex reduces relapse to methamphetamine-seeking and is associated with reduced activity in the rostral nucleus accumbens core
Addiction to the psychostimulant Methamphetamine (METH) is characterised by high rates of
relapse. Currently there are no approved effective pharmacotherapies for METH …
relapse. Currently there are no approved effective pharmacotherapies for METH …
The modulation of methamphetamine-induced behaviours by oxytocin in the nucleus accumbens core and subthalamic nucleus
SJ Baracz - 2022 - figshare.mq.edu.au
The psychostimulant methamphetamine (METH) is an addictive illicit drug, which is
commonly abused on a global scale. Repeat administration of the drug is associated with a …
commonly abused on a global scale. Repeat administration of the drug is associated with a …
[HTML][HTML] Towards an understanding of the neural mechanisms and therapeutic effects of oxytocin as a treatment for methamphetamine addiction
N Adams Everett - 2023 - figshare.mq.edu.au
Methamphetamine (METH) is a highly addictive psychostimulant, and currently there are no
approved pharmacotherapies for the treatment of METH addiction. The neuropeptide …
approved pharmacotherapies for the treatment of METH addiction. The neuropeptide …
Oxytocin in the nucleus accumbens core reduces reinstatement of methamphetamine‐seeking behaviour in rats
The psychostimulant methamphetamine (METH) is an addictive illicit drug. Systemic
administration of the neuropeptide oxytocin modulates METH‐related reward and METH …
administration of the neuropeptide oxytocin modulates METH‐related reward and METH …
[PDF][PDF] 34 Co-Author Contribution
The incentive sensitization theory of addiction posits that drug-associated stimuli become
imbued with incentive motivational properties, which drives pathological drug-seeking …
imbued with incentive motivational properties, which drives pathological drug-seeking …
Investigating the neural circuitry of methamphetamine addiction, and prelimbic cortex GABA involvement in the treatment effect of Oxytocin
KJ Robinson - 2022 - figshare.mq.edu.au
Abuse of methamphetamine (METH), a potent psychostimulant, elicits dysfunction of reward-
associated brain regions such as the nucleus accumbens (NAc) and prefrontal cortex (PFC) …
associated brain regions such as the nucleus accumbens (NAc) and prefrontal cortex (PFC) …
Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats
There is emerging evidence that the neuropeptide oxytocin may be utilised as a treatment
for various psychopathologies, including drug addictions. Here we used an animal model to …
for various psychopathologies, including drug addictions. Here we used an animal model to …